Centre to cap trade margins on anti-cancer drugs at 30%: SC seeks wider review
Daijiworld Media Network - New Delhi New Delhi, Oct 12: The Centre on Monday informed the Supreme Court that it has decided to cap trade margins on anti-cancer medicines at 30 per cent of the maximum retail price (MRP), while the apex court called for a broader review of medicine pricing....
Read the full report on Daijiworld
Story file
- Section
- Health
- Topics
- Courts & law, Health alerts
- Places
- Delhi
- First reported by
- Daijiworld
- Reporter
- daijiworld.com
- Published
- Monday, 12 October 2026, 10:10 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Daijiworld with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
